Concepedia

Mark J. Cayabyab

MJ

Statistics

Publications

24

Citations

2.8K

H-Index

19

Active since

1992

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Beth Israel Deaconess Medical Center

Howard Hughes Medical Institute

Institut de Biologie Moléculaire et Cellulaire

Mark J. Cayabyab is an author at Harvard University specializing in life sciences, immunology, and molecular virology.

ORCID

Publications per year

1992–2014

24

Publications

24

Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry

Michael Farzan, Tajib A. Mirzabekov, Peter Kolchinsky et al. · Cell · 1999 · 698 citations · Full text

, , +5

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Miyuki Azuma, Mark J. Cayabyab, David Buck et al. · The Journal of Experimental Medicine · 1992 · 325 citations · Full text

, , +17

CD40 preferentially costimulates activation of CD4+ T lymphocytes.

Mark J. Cayabyab, Joseph H. Phillips, Lewis L. Lanier · The Journal of Immunology · 1994 · 242 citations · Full text

, , +12

Increased CCR5 Affinity and Reduced CCR5/CD4 Dependence of a Neurovirulent Primary Human Immunodeficiency Virus Type 1 Isolate

Paul R. Gorry, Joann Taylor, Geoffrey H. Holm et al. · Journal of Virology · 2002 · 216 citations · Full text

, , +17

The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1

Hyeryun Choe, Michael Farzan, Miriam K. Konkel et al. · Journal of Virology · 1998 · 201 citations · Full text

, , +15

1–5 of 24